organisation
The Medicines Evaluation Board (MEB) assesses and guards the
efficacy, safety and quality of both human and
veterinary medicinal products. In the case of novel foods submitted
for authorisation, the MEB assesses their safety.
The MEB
- occupies a prominent position in the European authorisation
agency market.
- considers the protection of public health the main focus
of its assessment and monitoring activities.
- is the primary source of information on new medicinal products,
new applications and current risk information and works
actively to communicate this information.
- aims to achieve maximum transparency in its processes.
- offers added value, derived from its work in assessing and
monitoring the efficacy, safety and risks of medicinal products and
from the scientific advice it gives.